In a model of traumatic brain injury, HBOT promoted the expression of neurotrophic factors such as NGF, brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF), and neurotrophin-3 (NT-3) in vivo [154]. The gene discussed is GDNF; the disease is brain injury.